


Healthcare News Roundup: Generic
HSMN NewsFeed - 23 Oct 2007
Mylan Announces Settlement of Paroxetine Hydrochloride Extended-Release Tablets with GlaxoSmithKline
Mylan Announces Settlement of Paroxetine Hydrochloride Extended-Release Tablets with GlaxoSmithKline
HSMN NewsFeed - 19 Oct 2007
Hospira's Biosimilar Epoetin Retacrit(TM) Receives Positive Opinion Recommending EU Approval
Hospira's Biosimilar Epoetin Retacrit(TM) Receives Positive Opinion Recommending EU Approval
HSMN NewsFeed - 10 Oct 2007
Lannett Company Comments on Recent FDA Announcement for Levothyroxine Sodium
Lannett Company Comments on Recent FDA Announcement for Levothyroxine Sodium
HSMN NewsFeed - 5 Oct 2007
Caraco Pharmaceutical Laboratories Ltd. Announces Tentative FDA Approval for Generic Zyrtec Chewable(R)
Caraco Pharmaceutical Laboratories Ltd. Announces Tentative FDA Approval for Generic Zyrtec Chewable(R)
HSMN NewsFeed - 1 Oct 2007
Warner Chilcott Files Lawsuit Against Watson Laboratories, Inc. for Infringement of FEMCON FE Patent
Warner Chilcott Files Lawsuit Against Watson Laboratories, Inc. for Infringement of FEMCON FE Patent
HSMN NewsFeed - 27 Sep 2007
Adams Respiratory Therapeutics Files Lawsuit Against Perrigo for Infringement of Mucinex(R) Patent
Adams Respiratory Therapeutics Files Lawsuit Against Perrigo for Infringement of Mucinex(R) Patent
HSMN NewsFeed - 24 Sep 2007
Warner Chilcott Files Lawsuit Against Barr Laboratories, Inc. for Infringement of FEMCON FE Patent
Warner Chilcott Files Lawsuit Against Barr Laboratories, Inc. for Infringement of FEMCON FE Patent
HSMN NewsFeed - 6 Sep 2007
Ranbaxy Gains Approval to Manufacture and Market Carvedilol Tablets in the U.S. Market
Ranbaxy Gains Approval to Manufacture and Market Carvedilol Tablets in the U.S. Market
HSMN NewsFeed - 5 Sep 2007
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
HSMN NewsFeed - 5 Sep 2007
Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
HSMN NewsFeed - 30 Aug 2007
Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
